Vaso Comprehensive Income 2010-2024 | VASO

Vaso comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Vaso Comprehensive Income 2010-2024 | VASO

Vaso comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$202.3B
Intuitive Surgical (ISRG)$191.3B
Edwards Lifesciences (EW)$44.5B
Alcon (ALC)$42.5B
IQVIA Holdings (IQV)$36.3B
IDEXX Laboratories (IDXX)$33.9B
DexCom (DXCM)$31.3B
Waters (WAT)$22.2B
STERIS (STE)$20.6B
SONOVA HOLDING (SONVY)$19.8B
Hologic (HOLX)$16.5B
Fresenius Medical Care AG KGaA (FMS)$13.3B
Sysmex ADR (SSMXY)$11.7B
Globus Medical (GMED)$11.4B
Penumbra (PEN)$9.2B
Masimo (MASI)$9B
Glaukos (GKOS)$8.3B
Teleflex (TFX)$8.2B
Integer Holdings (ITGR)$4.5B
PROCEPT BioRobotics (PRCT)$4.4B
Veracyte (VCYT)$3.2B
Inari Medical (NARI)$3.1B
LivaNova (LIVN)$2.5B
Tandem Diabetes Care (TNDM)$2.4B
Nihon Kohden (NHNKY)$2.4B
TransMedics (TMDX)$2.1B
Elekta AB (EKTAY)$2B
Integra LifeSciences Holdings (IART)$1.7B
RxSight (RXST)$1.4B
Alphatec Holdings (ATEC)$1.3B